• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Know Labs

Study supports non-invasive glucose monitoring tech from Know Labs

April 21, 2023 By Sean Whooley

Know Labs KnowU Uband non-invasive glucose monitor

Know Labs (NYSE:KNW) today announced positive study data supporting its proprietary non-invasive glucose monitoring technology. Seattle-based Know Labs develops its proprietary Bio-RFID technology. It uses spectroscopy to direct electromagnetic energy through a substance or material to capture a unique molecular signature. This technology integrates into wearable, mobile or bench-top form factors. Know Labs developed the first […]

Filed Under: Clinical Trials, Diabetes, Featured, Patient Monitoring, Technology Tagged With: Know Labs

Know Labs establishes scientific advisory board to advance non-invasive glucose monitoring

March 22, 2023 By Sean Whooley

Know Labs KnowU Uband non-invasive glucose monitor

Know Labs (NYSE:KNW) announced today that it established a scientific advisory board to accelerate development for its glucose monitoring devices. Seattle-based Know Labs expects the members to advise on algorithm refinement, device development, clinical trial design and research publication strategy. They’ll work alongside the company’s current medical and regulatory advisory board members. Know Labs develops […]

Filed Under: Business/Financial News, Diabetes, Featured, Patient Monitoring, Personnel Tagged With: Know Labs, Personnel Moves

Know Labs inks partnerships to accelerate progress toward FDA clearance for glucose monitor

February 3, 2023 By Sean Whooley

Know Labs KnowU Uband non-invasive glucose monitor

Know Labs (NYSE:KNW) announced that it entered into a series of strategic partnerships as it looks to move toward a major regulatory nod. Seattle-based Know Labs develops the Bio-RFID technology. It uses spectroscopy to direct electromagnetic energy through a substance or material to capture a unique molecular signature. This technology integrates into wearable, mobile or bench-top […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Patient Monitoring, Technology Tagged With: Know Labs

Glucose monitor maker Know Labs names new CEO, makes other executive changes

January 27, 2023 By Sean Whooley

Know Labs KnowU Uband non-invasive glucose monitor

Know Labs (NYSE:KNW) announced that it named Ron Erickson as CEO as the company makes a handful of changes at the top. The Seattle-based non-invasive glucose monitor maker’s board unanimously named Erickson, its founder and chair, as CEO. Former CEO Phil Bosua stepped down as an executive officer of the company and board member. Know […]

Filed Under: Business/Financial News, Diabetes, Featured, Patient Monitoring Tagged With: Know Labs, Personnel Moves

Know Labs wins new glucose monitoring patent

January 4, 2023 By Sean Whooley

Know Labs KnowU Uband non-invasive glucose monitor

Know Labs (NYSE:KNW) announced today that it received a new patent equating its diagnostic technology to the current glucose monitoring standard. Seattle-based Know Labs develops the Bio-RFID technology. It uses spectroscopy to direct electromagnetic energy through a substance or material to capture a unique molecular signature. It integrate into wearable, mobile or bench-top form factors. […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Know Labs

Glucose monitor maker Know Labs expands leadership team

May 24, 2022 By Sean Whooley

Know Labs KnowU Uband non-invasive glucose monitor

Non-invasive glucose monitor developer Know Labs (OTCQB:KNWN) announced today that it added two executives to its leadership team. Seattle-based Know Labs — which aims to make the first non-invasive glucose monitor cleared by the FDA — added Steven Kent as its new chief product officer, along with Peter Conley as its CFO and SVP of […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Patient Monitoring, Technology Tagged With: Know Labs, Personnel, Personnel Moves

  • « Go to Previous Page
  • Page 1
  • Page 2

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS